BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34006390)

  • 1. The Nexus of cfDNA and Nuclease Biology.
    Han DSC; Lo YMD
    Trends Genet; 2021 Aug; 37(8):758-770. PubMed ID: 34006390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Biology of Cell-free DNA Fragmentation and the Roles of DNASE1, DNASE1L3, and DFFB.
    Han DSC; Ni M; Chan RWY; Chan VWH; Lui KO; Chiu RWK; Lo YMD
    Am J Hum Genet; 2020 Feb; 106(2):202-214. PubMed ID: 32004449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs.
    Zhou Z; Ma ML; Chan RWY; Lam WKJ; Peng W; Gai W; Hu X; Ding SC; Ji L; Zhou Q; Cheung PPH; Yu SCY; Teoh JYC; Szeto CC; Wong J; Wong VWS; Wong GLH; Chan SL; Hui EP; Ma BBY; Chan ATC; Chiu RWK; Chan KCA; Lo YMD; Jiang P
    Proc Natl Acad Sci U S A; 2023 Apr; 120(17):e2220982120. PubMed ID: 37075072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jagged Ends on Multinucleosomal Cell-Free DNA Serve as a Biomarker for Nuclease Activity and Systemic Lupus Erythematosus.
    Ding SC; Chan RWY; Peng W; Huang L; Zhou Z; Hu X; Volpi S; Hiraki LT; Vaglio A; Fenaroli P; Bocca P; Tam LS; Wong PCH; Tam LHP; Jiang P; Chiu RWK; Allen Chan KC; Dennis Lo YM
    Clin Chem; 2022 Jul; 68(7):917-926. PubMed ID: 35587043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclease deficiencies alter plasma cell-free DNA methylation profiles.
    Han DSC; Ni M; Chan RWY; Wong DKL; Hiraki LT; Volpi S; Jiang P; Lui KO; Chan KCA; Chiu RWK; Lo YMD
    Genome Res; 2021 Nov; 31(11):2008-2021. PubMed ID: 34470801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-free DNA in blood circulation is generated by DNase1L3 and caspase-activated DNase.
    Watanabe T; Takada S; Mizuta R
    Biochem Biophys Res Commun; 2019 Aug; 516(3):790-795. PubMed ID: 31255286
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Serpas L; Chan RWY; Jiang P; Ni M; Sun K; Rashidfarrokhi A; Soni C; Sisirak V; Lee WS; Cheng SH; Peng W; Chan KCA; Chiu RWK; Reizis B; Lo YMD
    Proc Natl Acad Sci U S A; 2019 Jan; 116(2):641-649. PubMed ID: 30593563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus.
    Hartl J; Serpas L; Wang Y; Rashidfarrokhi A; Perez OA; Sally B; Sisirak V; Soni C; Khodadadi-Jamayran A; Tsirigos A; Caiello I; Bracaglia C; Volpi S; Ghiggeri GM; Chida AS; Sanz I; Kim MY; Belmont HM; Silverman GJ; Clancy RM; Izmirly PM; Buyon JP; Reizis B
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33783474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fragmentomics of urinary cell-free DNA in nuclease knockout mouse models.
    Chen M; Chan RWY; Cheung PPH; Ni M; Wong DKL; Zhou Z; Ma ML; Huang L; Xu X; Lee WS; Wang G; Lui KO; Lam WKJ; Teoh JYC; Ng CF; Jiang P; Chan KCA; Chiu RWK; Lo YMD
    PLoS Genet; 2022 Jul; 18(7):e1010262. PubMed ID: 35793278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epistatic effects of Siglec-G and DNase1 or DNase1l3 deficiencies in the development of systemic lupus erythematosus.
    Korn MA; Steffensen M; Brandl C; Royzman D; Daniel C; Winkler TH; Nitschke L
    Front Immunol; 2023; 14():1095830. PubMed ID: 36969253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative characterization of rat deoxyribonuclease 1 (Dnase1) and murine deoxyribonuclease 1-like 3 (Dnase1l3).
    Napirei M; Wulf S; Eulitz D; Mannherz HG; Kloeckl T
    Biochem J; 2005 Jul; 389(Pt 2):355-64. PubMed ID: 15796714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo Correction.
    Chan RWY; Serpas L; Ni M; Volpi S; Hiraki LT; Tam LS; Rashidfarrokhi A; Wong PCH; Tam LHP; Wang Y; Jiang P; Cheng ASH; Peng W; Han DSC; Tse PPP; Lau PK; Lee WS; Magnasco A; Buti E; Sisirak V; AlMutairi N; Chan KCA; Chiu RWK; Reizis B; Lo YMD
    Am J Hum Genet; 2020 Nov; 107(5):882-894. PubMed ID: 33022220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of plasma levels and immunoactivities of different forms of circulating-free DNA in systemic lupus erythematosus patients].
    Huang J; Li Z; Cheng L; Zhang P; Li X; Feng G
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jul; 37(7):633-640. PubMed ID: 34140075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidimensional fragmentomic profiling of cell-free DNA released from patient-derived organoids.
    Kim J; Hong SP; Lee S; Lee W; Lee D; Kim R; Park YJ; Moon S; Park K; Cha B; Kim JI
    Hum Genomics; 2023 Oct; 17(1):96. PubMed ID: 37898819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil Extracellular Traps Profiles in Patients with Incident Systemic Lupus Erythematosus and Lupus Nephritis.
    Bruschi M; Bonanni A; Petretto A; Vaglio A; Pratesi F; Santucci L; Migliorini P; Bertelli R; Galetti M; Belletti S; Cavagna L; Moroni G; Franceschini F; Fredi M; Pazzola G; Allegri L; Sinico RA; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Ramoino P; Bianchini P; Puppo F; Pupo F; Negrini S; Mattana F; Emmi G; Garibotto G; Santoro D; Scolari F; Ravelli A; Tincani A; Cravedi P; Volpi S; Candiano G; Ghiggeri GM
    J Rheumatol; 2020 Mar; 47(3):377-386. PubMed ID: 31092713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting NETs using dual-active DNase1 variants.
    Englert H; Göbel J; Khong D; Omidi M; Wolska N; Konrath S; Frye M; Mailer RK; Beerens M; Gerwers JC; Preston RJS; Odeberg J; Butler LM; Maas C; Stavrou EX; Fuchs TA; Renné T
    Front Immunol; 2023; 14():1181761. PubMed ID: 37287977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine serum nucleases--contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3).
    Napirei M; Ludwig S; Mezrhab J; Klöckl T; Mannherz HG
    FEBS J; 2009 Feb; 276(4):1059-73. PubMed ID: 19154352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testing.
    Shi J; Zhang R; Li J; Zhang R
    Theranostics; 2020; 10(11):4737-4748. PubMed ID: 32308746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological, fragmentomic, and epigenetic characteristics of cell-free DNA in patients with lupus nephritis.
    Wang F; Miao HB; Pei ZH; Chen Z
    Front Immunol; 2022; 13():1001690. PubMed ID: 36578480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating cell-free DNA fragment analysis by microchip electrophoresis and its relationship with DNase I in cardiac diseases.
    Fujihara J; Takinami Y; Ueki M; Kimura-Kataoka K; Yasuda T; Takeshita H
    Clin Chim Acta; 2019 Oct; 497():61-66. PubMed ID: 31302100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.